Table 4.
PCAb | Peptide sequences* |
---|---|
Anti-Lin Tri (3) | CVFHQDa YLFTQDb CVFHQDa |
YLFTQDb GYMFTQ SKCNQP | |
KCSIRQ | |
LLACSY | |
LCQTCA | |
Anti-Bra Tri (4) | SIKWLEVSFWDW |
LIKWLEFIFYPW | |
YWKYES | |
KFGDLF | |
AVWGPAGPAFRPRWSc | |
DWRFSFRPWGLDLSS | |
AVWGPAGPAFRPRWSc | |
QMWFPAGPAWSSSCL | |
RDHLVFWTTSGPIFG | |
RDWHGAPYEVAVRSR | |
Anti-Penta (7) | KCCVSVYGYLYI |
LCCEGSYSNLYL | |
CCSRFLVNYSFY | |
CCPTPCYRNLLF | |
AVCCPCPSGSLPFFL | |
LVFYDDdLFFAWY | |
DLLWDHTRCLFFRGLSHCDVD | |
FEFDYNeCDRQPPPVRCFRLVD | |
VPVWLATFRWEFYPF | |
WLLCVLVSDGFEFCAF | |
FEFDYNe | |
LVFYDDd | |
WYWCYCIPLQLDDGC |
Random peptide sequence displayed on cpIII are preceded by the N-terminal sequence ADGA. Each superscript (a–e) marks a sequence that appears twice because it aligns into two different consensus groups.